AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 11,813 shares, a decline of 48.8% from the November 30th total of 23,090 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average trading volume of 22,365 shares, the days-to-cover ratio is currently 0.5 days. Based on an average trading volume of 22,365 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.3% of the shares of the stock are sold short.

AquaBounty Technologies Trading Up 20.4%

NASDAQ AQB opened at $1.02 on Friday. AquaBounty Technologies has a 1-year low of $0.50 and a 1-year high of $2.95. The company has a 50 day moving average of $1.07 and a 200-day moving average of $1.09. The firm has a market cap of $3.96 million, a price-to-earnings ratio of -1.23 and a beta of 1.36.

AquaBounty Technologies (NASDAQ:AQB) last released its quarterly earnings results on Tuesday, October 28th. The company reported ($0.36) EPS for the quarter, topping analysts’ consensus estimates of ($0.62) by $0.26.

Hedge Funds Weigh In On AquaBounty Technologies

A hedge fund recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP purchased a new stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned about 0.97% of AquaBounty Technologies at the end of the most recent reporting period. 8.92% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of AquaBounty Technologies in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.